Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT03343834
Eligibility Criteria:
Inclusion Criteria:
Retrospective study:
* Patient who underwent HSCT, in Saint-Antoine hospital,
* between 2010-2015,
* treated by rituximab for high level EBV-DNAemia (above 3.3 log copies/mL).
Prospective study:
* Patients who underwent HSCT, in Saint-Antoine hospital and la Pitié-Salpêtrière,
* in 2017-2018,
* treated by rituximab for high level EBV-DNAemia (above 10 000c/mL),
* And/or having post-transplant lymphoproliferative diseases(PTLD)
Exclusion Criteria:
* Refusal to sign the informed consent
* Patient non-beneficiary of the Social Security system
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03343834
Study Brief:
Protocol Section:
NCT03343834